sb 203580 has been researched along with s-nitroglutathione in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (s-nitroglutathione) | Trials (s-nitroglutathione) | Recent Studies (post-2010) (s-nitroglutathione) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 36 | 0 | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SU; Jeon, HK; Jung, NP | 1 |
1 other study(ies) available for sb 203580 and s-nitroglutathione
Article | Year |
---|---|
Association of the ERK1/2 and p38 kinase pathways with nitric oxide-induced apoptosis and cell cycle arrest in colon cancer cells.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Enzyme Activation; Flavonoids; Glutathione; Humans; Imidazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitric Oxide; Nitric Oxide Donors; Nitro Compounds; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Tumor Suppressor Protein p53 | 2005 |